Diabetes

Welcome Message

We are delighted to welcome you to the 20th International Summit on Diabetes, scheduled to take place on February 25–26, 2027, in the historic and dynamic city of London, United Kingdom. This prestigious global event brings together leading scientists, healthcare professionals, endocrinologists, dialectologists, researchers, academicians, industry experts, and policymakers to share knowledge, explore innovations, and advance the future of diabetes research and care.

About the Conference

The 20th International Summit on Diabetes 2027 provides an international platform for exploring the latest developments in diabetes prevention, diagnosis, treatment, management, and patient care. The summit will focus on emerging scientific discoveries, innovative therapeutic approaches, digital health technologies, artificial intelligence, precision medicine, glucose monitoring, insulin delivery, nutrition, lifestyle management, and strategies for preventing diabetes-related complications.

The conference will feature keynote presentations, plenary lectures, oral and poster presentations, scientific sessions, workshops, interactive discussions, and networking opportunities. It will encourage the exchange of groundbreaking research and practical knowledge among experts from different disciplines.

The summit also provides opportunities for researchers, clinicians, healthcare professionals, industry representatives, and emerging professionals to establish international collaborations, present their work, discuss current challenges, and explore future directions in diabetes science and healthcare.

We warmly invite you to join us in London on February 25–26, 2027, for an inspiring and enriching gathering dedicated to advancing diabetes research, innovation, prevention, and care worldwide.

Sessions & Tracks

Track 01: Advances in Diabetes Research & Pathophysiology
This track explores the latest developments in diabetes biology, disease mechanisms, genetics, biomarkers, and emerging research. Discussions will focus on understanding diabetes progression and identifying innovative approaches for prevention, diagnosis, and treatment.

Track 02: Type 1 & Type 2 Diabetes
This track focuses on the clinical and scientific aspects of Type 1 and Type 2 diabetes. Topics include disease management, risk factors, diagnosis, treatment strategies, complications, and emerging therapeutic approaches.

Track 03: Diabetes Prevention & Early Detection
This track highlights innovative strategies for preventing diabetes and identifying individuals at risk at an early stage. Discussions will cover screening, risk assessment, lifestyle interventions, prediabetes management, and population-based prevention programs.

Track 04: Diabetes Therapeutics & Pharmacological Innovations
This track explores emerging medications and therapeutic approaches for diabetes management. Topics include insulin therapy, oral medications, injectable therapies, combination treatments, clinical trials, and new drug development.

Track 05: Insulin Delivery & Glucose Monitoring Technologies
This track examines advances in insulin delivery systems and glucose monitoring. Discussions will include continuous glucose monitoring, insulin pumps, smart insulin pens, automated insulin delivery, wearable devices, and emerging diabetes technologies.

Track 06: Artificial Intelligence, Digital Health & Diabetes
This track explores the growing role of AI and digital technologies in diabetes care. Topics include AI-assisted diagnosis, predictive analytics, digital therapeutics, mobile health applications, remote monitoring, telemedicine, and personalized digital care.

Track 07: Precision Medicine & Personalized Diabetes Care
This track focuses on individualized approaches to diabetes prevention and treatment. Discussions will cover genomics, biomarkers, personalized therapies, risk prediction, precision nutrition, and patient-specific treatment strategies.

Track 08: Diabetes, Obesity & Metabolic Disorders
This track examines the complex relationship between diabetes, obesity, metabolic syndrome, and related disorders. Topics include metabolic health, weight management, insulin resistance, lifestyle interventions, and emerging obesity and diabetes therapies.

Track 09: Nutrition, Lifestyle & Exercise in Diabetes
This track highlights the importance of nutrition, physical activity, and healthy lifestyles in diabetes prevention and management. Discussions will explore dietary approaches, exercise programs, behavioural interventions, weight management, and sustainable lifestyle strategies.

Track 10: Diabetes Complications & Comorbidity Management
This track focuses on the prevention, diagnosis, and management of diabetes-related complications. Topics include cardiovascular disease, diabetic kidney disease, neuropathy, retinopathy, diabetic foot complications, and other associated conditions.

Track 11: Paediatric, Adolescent & Gestational Diabetes
This track addresses diabetes across different stages of life, with emphasis on paediatric, adolescent, and gestational diabetes. Discussions will explore early diagnosis, pregnancy management, maternal and child health, treatment challenges, and long-term outcomes.

Track 12: Diabetes Education & Patient-Centered Care
This track emphasizes patient education, self-management, health literacy, behavioural support, and shared decision-making. Participants will explore innovative approaches for empowering patients and improving adherence and quality of life.

Track 13: Diabetes Public Health & Global Health Strategies
This track examines diabetes as a growing global health challenge. Topics include population health, health inequalities, public health policies, community-based interventions, healthcare access, prevention programs, and global diabetes initiatives.

Track 14: Diabetes Technology, Wearables & Remote Patient Monitoring
This track focuses on innovative technologies transforming diabetes management. Discussions will include wearable sensors, connected devices, remote patient monitoring, smart health platforms, data analytics, and technology-enabled patient care.

Track 15: Future Trends & Innovations in Diabetes Care
This forward-looking track explores emerging research, technologies, therapies, and healthcare models shaping the future of diabetes management. Participants will discuss breakthrough innovations, next-generation treatments, research opportunities, and future directions in diabetes science and care.

Market Analysis

The global diabetes market is experiencing rapid growth, driven by the rising prevalence of diabetes, increasing healthcare expenditure, and advances in medicines, diagnostics, and digital health technologies. According to the International Diabetes Federation (IDF) 2025, approximately 589 million adults were living with diabetes globally in 2024, and this number is projected to reach 853 million by 2050.

The diabetes care market is also expanding through innovations such as GLP-1 therapies, SGLT2 inhibitors, continuous glucose monitoring (CGM), insulin pumps, smart devices, AI-powered analytics, telemedicine, and personalized diabetes management. Growing demand for early diagnosis, preventive care, and technology-enabled monitoring is creating significant opportunities for pharmaceutical, biotechnology, medical-device, and digital-health companies.

Against this backdrop, the 20th International Summit on Diabetes, scheduled for February 25–26, 2027, in London, UK, provides an international platform to explore emerging market trends, breakthrough therapies, innovative technologies, research developments, and future opportunities shaping the global diabetes healthcare landscape.